Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 4/20 | 0.52 |
| ▸ | CA6 | P23280 | 4/20 | 0.52 |
| ▸ | CA7 | P43166 | 4/20 | 0.52 |
| ▸ | CA9 | Q16790 | 4/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CASP2 | P42575 | 2/20 | 0.52 |
| ▸ | F13A1 | P00488 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | THPO | P40225 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL427900 | 0.98 | TDP1 (0.59) | TDP1CA12CA6CA7CA9 | |
| Hydrochloric Acid SCHEMBL28341342 | 0.96 | UBE2N (0.58) | TDP1CA12CA6CA7CA9 | |
| Hydrochloric Acid SCHEMBL6114403 | 0.96 | UBE2N (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL7522951 | 0.93 | ALOX15 (0.56) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL4562189 | 0.93 | PAOX (0.55) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL4562850 | 0.93 | PAOX (0.53) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL4562729 | 0.91 | PAOX (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL4561516 | 0.91 | PAOX (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL2182287 | 0.91 | TDP1 (0.56) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL322792 | 0.89 | ALOX15 (0.54) | TDP1CA12CA6CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0512423-B1 | Aqueous solutions of cationic polyamidoamine resins | HOECHST AG (DE) | 1998-07-22 | — | — | EP | claimed |
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | BASF SE (DE) | 2024-02-27 | — | — | US | disclosed |
| EP-4190882-A1 | USE WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-11634654-B2 | Polycarboxylic acid-based additives for fuels and lubricants | BASF SE (DE) | 2023-04-25 | — | — | US | disclosed |
| EP-3653689-B1 | USE WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE (DE) | 2023-03-29 | — | — | EP | disclosed |
| US-20230002790-A1 | POLY(Beta-AMINO ESTER) NANOPARTICLES FOR THE NON-VIRAL DELIVERY OF PLASMID DNA FOR GENE EDITING AND RETINAL GENE THERAPY | THE JOHNS HOPKINS UNIVERSITY | 2023-01-05 | — | — | US | disclosed |
| US-20220395589-A1 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | THE JOHNS HOPKINS UNIVERSTY | 2022-12-15 | — | — | US | disclosed |
| US-20220154219-A1 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | THE JOHNS HOPKINS UNIVERSITY | 2022-05-19 | — | — | US | disclosed |
| US-20210363451-A1 | USE OF NITROGEN COMPOUNDS QUATERNISED WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE (DE) | 2021-11-25 | — | — | US | disclosed |
| US-11168273-B2 | Polycarboxylic acid-based additives for fuels and lubricants | BASF SE (DE) | 2021-11-09 | — | — | US | disclosed |
| EP-0512423-A2 | Aqueous solutions of cationic polyamidoamine resins | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-11-11 | — | — | EP | disclosed |
| US-5074884-A | PROCESS FOR THE DYEING OF LEATHER WITH ANIONIC DYES AND POLYAMINOAMIDE RESIN AS DYEING AUXILIARY | BAYER AKTIENGESELLSCHAFT (DE) | 1991-12-24 | — | — | US | disclosed |
| EP-0423561-A1 | Process for dyeing leather | BAYER AG (DE) | 1991-04-24 | — | — | EP | disclosed |
| US-4992130-A | Bonding two hydrophobic thermoplastic resins, one of which contains a hydrophilic colloids | AGFA-GEVAERT (BE) | 1991-02-12 | — | — | US | disclosed |
| EP-0396824-A1 | Process for the production of a multicolour liquid crystal display device | AGFA-GEVAERT N.V. (BE) | 1990-11-14 | — | — | EP | disclosed |
| EP-0351456-A1 | Process for the preparation of a laminate | AGFA-GEVAERT N.V. (BE) | 1990-01-24 | — | — | EP | disclosed |
| US-4753966-A | MIXTURE OF ZINC CARBOXYLIC ACID SALT AND AMINE CONTAINING COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1988-06-28 | — | — | US | disclosed |
| US-4689374-A | Water soluble polyamidoaminepolyamine having weight average molecular weight of at least 5×105 | W. R. GRACE & CO. (US) | 1987-08-25 | — | — | US | disclosed |
| EP-0031899-B1 | SELF-CROSSLINKING WATER-SOLUBLE REACTION PRODUCTS, PROCESS FOR PRODUCING BINDING AGENTS FROM SUCH PRODUCTS, AND USE OF THE PRODUCTS TO INCREASE THE WET STRENGTH OF PAPER | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-06 | — | — | EP | disclosed |
| EP-0031899-A1 | Self-crosslinking water-soluble reaction products, process for producing binding agents from such products, and use of the products to increase the wet strength of paper | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | DGKI, DERL1, DEK | TDP1 1202/4885CA12 1074/4885CA6 1114/4885 |
| US-20210363451-A1 | USE OF NITROGEN COMPOUNDS QUATERNISED WITH ALKYLENE OXIDE AND HYDROCARBYL-SUBSTITUTED POLYCARBOXYLIC ACID AS ADDITIVES IN FUELS AND LUBRICANTS | DGKI, DERL1, DEK | TDP1 1202/4885CA12 1074/4885CA6 1114/4885 |
| US-20220154219-A1 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | PBK, MICA, STAT3 | TDP1 4009/4885CA12 3289/4885CA6 3564/4885 |
| US-20220395589-A1 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | LNPEP, EEA1, CLTB | TDP1 4011/4885CA12 1671/4885CA6 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.